[Ip-health] HAI/TWN/BD statement on PIP Framework at the WHO EB 130

Patrick Durisch durisch at ladb.ch
Fri Jan 20 07:02:40 PST 2012

EB 130 – agenda item 6.9
“Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report on the work of the Advisory Group”

Statement of Health Action International
Made by Patrick Durisch, BD/HAI

I make this statement on behalf of Health Action International, Third World Network and the Berne Declaration.

The PIP Framework’s ability to deliver an equitable response to the influenza threat depends now on implementation. Of particular importance is the response to outstanding matters such as SMTA2 and the decisions to be made by the Advisory Group, such as on monetary contributions to be made by commercial entities. In this regard transparency is a crucial aspect. 

We therefore would like to request the following: 

1. That the CV of Advisory Group members, their individual “WHO Declaration of Interests” as well as all Secretariat inputs mentioned in paragraph 13 of EB130/18 be made public. 

2. That the Secretariat and Advisory Group be guided by the principles of equity and transparency. For example the process and methodologies to determine partnership contributions and the running costs of the network, and the terms and conditions of SMTAs should be made transparent. 

3. That measures be put in place to avoid undue influence of commercial entities on the decisions of the Advisory Group. Of particular concern is paragraph 12 which suggests that manufacturers should take the lead when defining financial contributions by each company and the implementation mechanism. The PIP Framework is clear: the process must be driven by the DG and Advisory Group with ‘input’ from manufacturers - not vice versa. 

4. That public interest NGOs be consulted at all stages of decision-making. 

5. That SMTAs be implemented immediately: while rapid virus sharing is important, so is the recipient’s legal commitment to benefit sharing. 

Finally, media reports suggest moves to censor and limit data sharing of risky H5N1 research which has led to a highly contagious strain. This may have implications for the PIP framework and will result in some select countries having access to data to the exclusion of others. Thus any discussion on this matter should be inclusive, involving the entire WHO membership.

More information about the Ip-health mailing list